Clinical Trial Update: Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation [Phase 2]

View source ↗

Summary

A Phase 2 study assessed the safety implications of overestimating the meal insulin bolus within a dual-hormone closed-loop system in individuals with Type 1 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED